TEMPEST THERAPEUTICS INC. - COMMON STOCK
0.9055
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.0119
+1.33%
Today's range
0.8660 - 0.9282
ISIN
N/A
Source
NASDAQ
-
Tempest Presents Promising Preclinical Data on Two Oncology Programs at the 2022 AACR Annual Meeting
08 Apr 2022 13:00:00 By Nasdaq GlobeNewswire
-
Tempest Reports Year End 2021 Financial Results and Provides Business Update
29 Mar 2022 16:00:00 By Nasdaq GlobeNewswire
-
Tempest to Present at the 32nd Annual Oppenheimer Healthcare Conference
10 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
08 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
Tempest to Present at the 11th Annual SVB Leerink Healthcare Conference
09 Feb 2022 08:00:03 By Nasdaq GlobeNewswire
-
Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
Tempest to Present at Two Upcoming Investor Conferences in November
09 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
08 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
01 Oct 2021 08:00:01 By Nasdaq GlobeNewswire
-
20 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
13 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Tempest to Present at Upcoming Investor Conferences
09 Sep 2021 16:01:00 By Nasdaq GlobeNewswire